Current Perspectives on Severe Drug Eruption.

Zhang, Jingzhan; Lei, Zixian; Xu, Chen; Zhao, Juan; Kang, Xiaojing

Zhang, Jingzhan; Lei, Zixian; Xu, Chen; Zhao, Juan; Kang, Xiaojing.

Afiliación

Zhang J; Department of Dermatology, People's Hospital of Xinjiang Uygur Autonomous Region, Tianshan District, No. 91, Tianchi Road, Urumqi, 830001, Xinjiang, China.
Lei Z; Xinjiang Key Laboratory of Dermatology Research, Urumqi, Xinjiang, China.
Xu C; Department of Dermatology, People's Hospital of Xinjiang Uygur Autonomous Region, Tianshan District, No. 91, Tianchi Road, Urumqi, 830001, Xinjiang, China.
Zhao J; Xinjiang Key Laboratory of Dermatology Research, Urumqi, Xinjiang, China.
Kang X; Department of Dermatology, People's Hospital of Xinjiang Uygur Autonomous Region, Tianshan District, No. 91, Tianchi Road, Urumqi, 830001, Xinjiang, China.

Clin Rev Allergy Immunol ; 61(3): 282-298, 2021 Dec.

Article en En | MEDLINE | ID: mdl-34273058

Asunto(s)

Erupciones por Medicamentos; Erupciones por Medicamentos/patología; Erupciones por Medicamentos/terapia; Humanos; Factores de Riesgo; Índice de Severidad de la Enfermedad

Palabras clave

Acute generalized exanthematous pustulosis; Drug reaction with eosinophilia and systemic symptoms; Severe drug eruption; Stevens-Johnson syndrome; Toxic epidermal necrolysis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Erupciones por Medicamentos Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Rev Allergy Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google